[HTML][HTML] FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Diagnostics, 2021 - mdpi.com
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm… - Diagnostics (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
Background We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

FDG-PET/CT for response monitoring in metastatic breast cancer: The feasibility and benefits of applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm… - …, 2021 - portal.findresearcher.sdu.dk
BACKGROUND: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

[PDF][PDF] FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Bone, 2021 - pdfs.semanticscholar.org
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - …, 2021 - search.proquest.com
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.

M Vogsen, JL Bülow, L Ljungstrøm… - Diagnostics (Basel …, 2021 - europepmc.org
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

[HTML][HTML] FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Diagnostics, 2021 - ncbi.nlm.nih.gov
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.

M Vogsen, JL Bülow, L Ljungstrøm… - Diagnostics (2075 …, 2021 - search.ebscohost.com
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …